What is the projected market valuation of the Sequencing Reagents Market by 2035?

The Sequencing Reagents Market is projected to reach a valuation of 30.03 USD Billion by 2035. Read More

What was the market valuation of the Sequencing Reagents Market in 2024?

In 2024, the Sequencing Reagents Market was valued at 10.26 USD Billion. Read More

What is the expected CAGR for the Sequencing Reagents Market during the forecast period 2025 - 2035?

The expected CAGR for the Sequencing Reagents Market during the forecast period 2025 - 2035 is 10.25%. Read More

Which companies are considered key players in the Sequencing Reagents Market?

Key players in the Sequencing Reagents Market include Illumina, Thermo Fisher Scientific, Roche, Qiagen, and Agilent Technologies. Read More

What are the main segments of the Sequencing Reagents Market?

The main segments of the Sequencing Reagents Market include Sequencing Technology, Application, Sample Type, Read Length, and End User. Read More

How much is the Next-Generation Sequencing segment projected to be worth by 2035?

The Next-Generation Sequencing segment is projected to be worth 20.0 USD Billion by 2035. Read More

What is the projected value of the Clinical Laboratories segment by 2035?

The Clinical Laboratories segment is projected to reach a value of 7.25 USD Billion by 2035. Read More

What is the expected growth for the Single-Cell Sequencing application by 2035?

The Single-Cell Sequencing application is expected to grow to 8.03 USD Billion by 2035. Read More

What is the projected market size for RNA sample types by 2035?

The projected market size for RNA sample types is expected to reach 8.0 USD Billion by 2035. Read More

How does the market for Targeted Panels compare to other sample types by 2035?

The market for Targeted Panels is projected to be 12.03 USD Billion by 2035, indicating strong growth compared to other sample types. Read More

Sequencing Reagents Market

ID: MRFR/HC/39176-HCR

128 Pages

Rahul Gotadki

Last Updated: May 15, 2026

Sequencing Reagents Market Research Report: By Sequencing Technology (Next-Generation Sequencing (NGS), Sanger Sequencing), By Application (Genomics, Transcriptomics, Epigenomics, Single-Cell Sequencing), By Sample Type (DNA, RNA, Targeted Panel), By Read Length (Short-Read Sequencing, Long-Read Sequencing), By End User (Academic and Research Institutions, Clinical Laboratories, Pharmaceutical and Biotechnology Companies) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035.

Sequencing Reagents Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)10.25%

2024 Market Size$ 10.26 Billion

2025 Market Size$ 11.32 Billion

2035 Market Size$ 30.03 Billion

Key Players

Illumina

Thermo Fisher Scientific

Roche

Qiagen

Agilent Technologies

Bio-Rad Laboratories

Trends

Rise of Personalized Medicine
Advancements in Automation
Collaborative Research Initiatives

Opportunities

Government Initiatives and Funding
Increasing Demand for Genomic Research
Rising Prevalence of Genetic Disorders

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Sequencing Technology (USD Billion) | |
  1. 4.1.1 Next-Generation Sequencing | |
  2. 4.1.2 Sanger Sequencing |
2. 4.2 Healthcare, BY Application (USD Billion) | |
  1. 4.2.1 Genomics | |
  2. 4.2.2 Transcriptomics | |
  3. 4.2.3 Epigenomics | |
  4. 4.2.4 Single-Cell Sequencing |
3. 4.3 Healthcare, BY Sample Type (USD Billion) | |
  1. 4.3.1 DNA | |
  2. 4.3.2 RNA | |
  3. 4.3.3 Targeted Panels |
4. 4.4 Healthcare, BY Read Length (USD Billion) | |
  1. 4.4.1 Short-Read Sequencing | |
  2. 4.4.2 Long-Read Sequencing |
5. 4.5 Healthcare, BY End User (USD Billion) | |
  1. 4.5.1 Academic and Research Institutions | |
  2. 4.5.2 Clinical Laboratories | |
  3. 4.5.3 Pharmaceutical and Biotechnology Companies |
6. 4.6 Healthcare, BY Region (USD Billion) | |
  1. 4.6.1 North America | | |
    1. 4.6.1.1 US | | |
    2. 4.6.1.2 Canada | |
  2. 4.6.2 Europe | | |
    1. 4.6.2.1 Germany | | |
    2. 4.6.2.2 UK | | |
    3. 4.6.2.3 France | | |
    4. 4.6.2.4 Russia | | |
    5. 4.6.2.5 Italy | | |
    6. 4.6.2.6 Spain | | |
    7. 4.6.2.7 Rest of Europe | |
  3. 4.6.3 APAC | | |
    1. 4.6.3.1 China | | |
    2. 4.6.3.2 India | | |
    3. 4.6.3.3 Japan | | |
    4. 4.6.3.4 South Korea | | |
    5. 4.6.3.5 Malaysia | | |
    6. 4.6.3.6 Thailand | | |
    7. 4.6.3.7 Indonesia | | |
    8. 4.6.3.8 Rest of APAC | |
  4. 4.6.4 South America | | |
    1. 4.6.4.1 Brazil | | |
    2. 4.6.4.2 Mexico | | |
    3. 4.6.4.3 Argentina | | |
    4. 4.6.4.4 Rest of South America | |
  5. 4.6.5 MEA | | |
    1. 4.6.5.1 GCC Countries | | |
    2. 4.6.5.2 South Africa | | |
    3. 4.6.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Illumina (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Thermo Fisher Scientific (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Roche (CH) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Qiagen (DE) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Agilent Technologies (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Bio-Rad Laboratories (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 New England Biolabs (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 PerkinElmer (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Takara Bio (JP) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
7. 6.4 US MARKET ANALYSIS BY APPLICATION |
8. 6.5 US MARKET ANALYSIS BY SAMPLE TYPE |
9. 6.6 US MARKET ANALYSIS BY READ LENGTH |
10. 6.7 US MARKET ANALYSIS BY END USER |
11. 6.8 CANADA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
12. 6.9 CANADA MARKET ANALYSIS BY APPLICATION |
13. 6.10 CANADA MARKET ANALYSIS BY SAMPLE TYPE |
14. 6.11 CANADA MARKET ANALYSIS BY READ LENGTH |
15. 6.12 CANADA MARKET ANALYSIS BY END USER |
16. 6.13 EUROPE MARKET ANALYSIS |
17. 6.14 GERMANY MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
18. 6.15 GERMANY MARKET ANALYSIS BY APPLICATION |
19. 6.16 GERMANY MARKET ANALYSIS BY SAMPLE TYPE |
20. 6.17 GERMANY MARKET ANALYSIS BY READ LENGTH |
21. 6.18 GERMANY MARKET ANALYSIS BY END USER |
22. 6.19 UK MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
23. 6.20 UK MARKET ANALYSIS BY APPLICATION |
24. 6.21 UK MARKET ANALYSIS BY SAMPLE TYPE |
25. 6.22 UK MARKET ANALYSIS BY READ LENGTH |
26. 6.23 UK MARKET ANALYSIS BY END USER |
27. 6.24 FRANCE MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
28. 6.25 FRANCE MARKET ANALYSIS BY APPLICATION |
29. 6.26 FRANCE MARKET ANALYSIS BY SAMPLE TYPE |
30. 6.27 FRANCE MARKET ANALYSIS BY READ LENGTH |
31. 6.28 FRANCE MARKET ANALYSIS BY END USER |
32. 6.29 RUSSIA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
33. 6.30 RUSSIA MARKET ANALYSIS BY APPLICATION |
34. 6.31 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE |
35. 6.32 RUSSIA MARKET ANALYSIS BY READ LENGTH |
36. 6.33 RUSSIA MARKET ANALYSIS BY END USER |
37. 6.34 ITALY MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
38. 6.35 ITALY MARKET ANALYSIS BY APPLICATION |
39. 6.36 ITALY MARKET ANALYSIS BY SAMPLE TYPE |
40. 6.37 ITALY MARKET ANALYSIS BY READ LENGTH |
41. 6.38 ITALY MARKET ANALYSIS BY END USER |
42. 6.39 SPAIN MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
43. 6.40 SPAIN MARKET ANALYSIS BY APPLICATION |
44. 6.41 SPAIN MARKET ANALYSIS BY SAMPLE TYPE |
45. 6.42 SPAIN MARKET ANALYSIS BY READ LENGTH |
46. 6.43 SPAIN MARKET ANALYSIS BY END USER |
47. 6.44 REST OF EUROPE MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
48. 6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
49. 6.46 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE |
50. 6.47 REST OF EUROPE MARKET ANALYSIS BY READ LENGTH |
51. 6.48 REST OF EUROPE MARKET ANALYSIS BY END USER |
52. 6.49 APAC MARKET ANALYSIS |
53. 6.50 CHINA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
54. 6.51 CHINA MARKET ANALYSIS BY APPLICATION |
55. 6.52 CHINA MARKET ANALYSIS BY SAMPLE TYPE |
56. 6.53 CHINA MARKET ANALYSIS BY READ LENGTH |
57. 6.54 CHINA MARKET ANALYSIS BY END USER |
58. 6.55 INDIA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
59. 6.56 INDIA MARKET ANALYSIS BY APPLICATION |
60. 6.57 INDIA MARKET ANALYSIS BY SAMPLE TYPE |
61. 6.58 INDIA MARKET ANALYSIS BY READ LENGTH |
62. 6.59 INDIA MARKET ANALYSIS BY END USER |
63. 6.60 JAPAN MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
64. 6.61 JAPAN MARKET ANALYSIS BY APPLICATION |
65. 6.62 JAPAN MARKET ANALYSIS BY SAMPLE TYPE |
66. 6.63 JAPAN MARKET ANALYSIS BY READ LENGTH |
67. 6.64 JAPAN MARKET ANALYSIS BY END USER |
68. 6.65 SOUTH KOREA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
69. 6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
70. 6.67 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE |
71. 6.68 SOUTH KOREA MARKET ANALYSIS BY READ LENGTH |
72. 6.69 SOUTH KOREA MARKET ANALYSIS BY END USER |
73. 6.70 MALAYSIA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
74. 6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION |
75. 6.72 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE |
76. 6.73 MALAYSIA MARKET ANALYSIS BY READ LENGTH |
77. 6.74 MALAYSIA MARKET ANALYSIS BY END USER |
78. 6.75 THAILAND MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
79. 6.76 THAILAND MARKET ANALYSIS BY APPLICATION |
80. 6.77 THAILAND MARKET ANALYSIS BY SAMPLE TYPE |
81. 6.78 THAILAND MARKET ANALYSIS BY READ LENGTH |
82. 6.79 THAILAND MARKET ANALYSIS BY END USER |
83. 6.80 INDONESIA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
84. 6.81 INDONESIA MARKET ANALYSIS BY APPLICATION |
85. 6.82 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE |
86. 6.83 INDONESIA MARKET ANALYSIS BY READ LENGTH |
87. 6.84 INDONESIA MARKET ANALYSIS BY END USER |
88. 6.85 REST OF APAC MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
89. 6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION |
90. 6.87 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE |
91. 6.88 REST OF APAC MARKET ANALYSIS BY READ LENGTH |
92. 6.89 REST OF APAC MARKET ANALYSIS BY END USER |
93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
94. 6.91 BRAZIL MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
95. 6.92 BRAZIL MARKET ANALYSIS BY APPLICATION |
96. 6.93 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE |
97. 6.94 BRAZIL MARKET ANALYSIS BY READ LENGTH |
98. 6.95 BRAZIL MARKET ANALYSIS BY END USER |
99. 6.96 MEXICO MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
100. 6.97 MEXICO MARKET ANALYSIS BY APPLICATION |
101. 6.98 MEXICO MARKET ANALYSIS BY SAMPLE TYPE |
102. 6.99 MEXICO MARKET ANALYSIS BY READ LENGTH |
103. 6.100 MEXICO MARKET ANALYSIS BY END USER |
104. 6.101 ARGENTINA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
105. 6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION |
106. 6.103 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE |
107. 6.104 ARGENTINA MARKET ANALYSIS BY READ LENGTH |
108. 6.105 ARGENTINA MARKET ANALYSIS BY END USER |
109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE |
112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY READ LENGTH |
113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
114. 6.111 MEA MARKET ANALYSIS |
115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE |
118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY READ LENGTH |
119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY END USER |
120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE |
123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY READ LENGTH |
124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY END USER |
125. 6.122 REST OF MEA MARKET ANALYSIS BY SEQUENCING TECHNOLOGY |
126. 6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION |
127. 6.124 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE |
128. 6.125 REST OF MEA MARKET ANALYSIS BY READ LENGTH |
129. 6.126 REST OF MEA MARKET ANALYSIS BY END USER |
130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
131. 6.128 RESEARCH PROCESS OF MRFR |
132. 6.129 DRO ANALYSIS OF HEALTHCARE |
133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
136. 6.133 HEALTHCARE, BY SEQUENCING TECHNOLOGY, 2024 (% SHARE) |
137. 6.134 HEALTHCARE, BY SEQUENCING TECHNOLOGY, 2024 TO 2035 (USD Billion) |
138. 6.135 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
139. 6.136 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
140. 6.137 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE) |
141. 6.138 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion) |
142. 6.139 HEALTHCARE, BY READ LENGTH, 2024 (% SHARE) |
143. 6.140 HEALTHCARE, BY READ LENGTH, 2024 TO 2035 (USD Billion) |
144. 6.141 HEALTHCARE, BY END USER, 2024 (% SHARE) |
145. 6.142 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
147. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.2.5 BY END USER, 2025-2035 (USD Billion) |
149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.3.5 BY END USER, 2025-2035 (USD Billion) |
150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.4.5 BY END USER, 2025-2035 (USD Billion) |
151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.5.5 BY END USER, 2025-2035 (USD Billion) |
152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.6.5 BY END USER, 2025-2035 (USD Billion) |
153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.7.5 BY END USER, 2025-2035 (USD Billion) |
154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.8.5 BY END USER, 2025-2035 (USD Billion) |
155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.9.5 BY END USER, 2025-2035 (USD Billion) |
156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.10.5 BY END USER, 2025-2035 (USD Billion) |
157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.11.5 BY END USER, 2025-2035 (USD Billion) |
158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.12.5 BY END USER, 2025-2035 (USD Billion) |
159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.13.5 BY END USER, 2025-2035 (USD Billion) |
160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.14.5 BY END USER, 2025-2035 (USD Billion) |
161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.15.5 BY END USER, 2025-2035 (USD Billion) |
162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.16.5 BY END USER, 2025-2035 (USD Billion) |
163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.17.5 BY END USER, 2025-2035 (USD Billion) |
164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.18.5 BY END USER, 2025-2035 (USD Billion) |
165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.19.5 BY END USER, 2025-2035 (USD Billion) |
166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.20.5 BY END USER, 2025-2035 (USD Billion) |
167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.21.5 BY END USER, 2025-2035 (USD Billion) |
168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.22.5 BY END USER, 2025-2035 (USD Billion) |
169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.23.5 BY END USER, 2025-2035 (USD Billion) |
170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.24.5 BY END USER, 2025-2035 (USD Billion) |
171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.25.5 BY END USER, 2025-2035 (USD Billion) |
172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.26.5 BY END USER, 2025-2035 (USD Billion) |
173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.27.5 BY END USER, 2025-2035 (USD Billion) |
174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.28.5 BY END USER, 2025-2035 (USD Billion) |
175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.29.5 BY END USER, 2025-2035 (USD Billion) |
176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY SEQUENCING TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY READ LENGTH, 2025-2035 (USD Billion) | |
  5. 7.30.5 BY END USER, 2025-2035 (USD Billion) |
177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
178. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Sequencing Reagents Market Segmentation

Sequencing Reagents Market By Sequencing Technology (USD Billion, 2025-2035)

Next-Generation Sequencing
Sanger Sequencing

Sequencing Reagents Market By Application (USD Billion, 2025-2035)

Genomics
Transcriptomics
Epigenomics
Single-Cell Sequencing

Sequencing Reagents Market By Sample Type (USD Billion, 2025-2035)

DNA
RNA
Targeted Panels

Sequencing Reagents Market By Read Length (USD Billion, 2025-2035)

Short-Read Sequencing
Long-Read Sequencing

Sequencing Reagents Market By End User (USD Billion, 2025-2035)

Academic and Research Institutions
Clinical Laboratories
Pharmaceutical and Biotechnology Companies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”